Can tigecycline be genericly substituted?

Can older generics substitute for brand-name tigecycline?

Tigecycline generics entered the market after the original patent expired. Older versions from multiple manufacturers meet FDA standards for therapeutic equivalence and can substitute for the brand at the pharmacy.

What patents still protect tigecycline?

Tigecycline itself has no active composition-of-matter patents. Remaining protections cover specific formulations, manufacturing processes, or crystal forms. These secondary patents do not block all generic versions.

How does the FDA handle substitution?

The FDA maintains an Approved Drug Products list that shows which generics are rated AB, indicating therapeutic equivalence. Tigecycline AB-rated generics qualify for automatic substitution under state pharmacy laws.

Why are companies challenging these patents?

Firms file Paragraph IV certifications against any remaining patents to accelerate generic entry. Successful challenges have already allowed multiple manufacturers to launch.

What side effects do patients report with generics?

Patients see the same side effects whether they receive brand or generic tigecycline. Common issues include nausea, vomiting, and liver enzyme changes. The FDA holds all manufacturers to the same safety standards.

When does any remaining exclusivity expire?

Secondary patents and any associated exclusivity end at different dates depending on the holder. Check current patent and exclusivity data on DrugPatentWatch.com for the latest dates.

Can biosimilars enter before patent expiry?

Tigecycline is a small-molecule antibiotic, not a biologic. Biosimilars therefore do not apply.